FuturRupt
Sign inCreate free
account
← all companies
LI

Life Biosciences

privatefounded 2017USACheating Death
// WHAT THEY DO

Life Biosciences, co-founded by Harvard aging researcher David Sinclair, develops partial epigenetic reprogramming therapies that restore youthful function to aged cells without erasing their identity. Its lead program ER-100 delivers reprogramming factors (OSK) to the eye and aims to restore vision lost to optic-nerve diseases such as NAION and glaucoma.

// 8 SIGNALS ON FILE
  • 8 OCT 2026 · Product Launches

    Life Biosciences Announces First-in-Human Data from Ongoing Phase 1 Trial Evaluating ER-100 in Optic Neuropathies

  • 1 OCT 2026 · Breakthroughs & Milestones

    Life Biosciences to Present First-in-Human Data from Ongoing Phase 1 Trial Evaluating ER-100 in Optic Neuropathies at Eyecelerator 2026

// MEMBERS.ONLY

See the full dossier

Create a free account to read all 8 signals, the milestone timeline and catalyst watch for Life Biosciences.

Create a free account
Free · no card needed · Sign in
// WEEKLY.UPDATES

Every Monday: up to 5 major breakthroughs and launches, explained in plain English. Free. No account needed.

One email a week. Unsubscribe anytime.